Kaskela Law LLC Announces Stockholder Investigation of Evolus, Inc. (EOLS) and Encourages Long-Term EOLS Stockholders to Contact the Firm

PHILADELPHIA, April 16, 2022 (World NEWSWIRE) — Kaskela Legislation LLC announces that it is investigating Evolus, Inc. (“Evolus” or the “Company”) (NASDAQ: EOLS) on behalf of the Company’s extensive-time period shareholders.

Evolus stockholders who obtained or obtained shares of the Company’s typical stock prior to May well 20, 2019 are encouraged to speak to Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email ([email protected]) or online at https://kaskelalaw.com/instances/evolus-inc/, for extra details about this investigation and their lawful rights and selections.

Lately an amended securities fraud grievance was submitted versus Evolus on behalf of investors who bought shares of the Company’s prevalent stock among February 1, 2019 and July 6, 2020. According to the grievance, for the duration of that time period of time Evolus manufactured a series of untrue and misleading statements about Jeuveau, the Company’s BOTOX solution.

As in-depth in the amended criticism, on July 6, 2020, the Global Trade Fee located that “Evolus misappropriated Medytox’s trade insider secrets resulting in substantial injury to the domestic marketplace.” On this news, the Company’s shares dropped to $3.35 per share in excess of the upcoming two trading days, representing a decline of 37%, damaging traders.  

Subsequently, Evolus disclosed that in February 2021, “upon entering into specified agreements to settle mental home disputes relating to Jeuveau, the Company agreed to pay out to Allergan and Medytox $35 [million] … and issued 6,762,652 shares of its typical stock to Medytox.”

The investigation seeks to decide regardless of whether the customers of Evolus’ board of administrators breached their fiduciary duties to the Organization and its stockholders in connection with the over alleged misconduct.

Kaskela Legislation LLC signifies investors in securities fraud, corporate governance, and merger & acquisition litigation.  For added information and facts about the organization be sure to stop by www.kaskelalaw.com. This observe may perhaps represent attorney promoting in sure jurisdictions.

Get in touch with:

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA Regulation LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com 


Primary Logo